Logo image of EXOD

EXODUS MOVEMENT INC - A (EXOD) Stock Fundamental Analysis

USA - NYSEARCA:EXOD - US30209R1068 - Common Stock

28.51 USD
-0.39 (-1.35%)
Last: 9/26/2025, 8:04:02 PM
28.317 USD
-0.19 (-0.68%)
After Hours: 9/26/2025, 8:04:02 PM
Fundamental Rating

6

Taking everything into account, EXOD scores 6 out of 10 in our fundamental rating. EXOD was compared to 281 industry peers in the Software industry. While EXOD has a great health rating, its profitability is only average at the moment. EXOD is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes EXOD very considerable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year EXOD was profitable.
EXOD had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: EXOD reported negative net income in multiple years.
EXOD had a positive operating cash flow in 4 of the past 5 years.
EXOD Yearly Net Income VS EBIT VS OCF VS FCFEXOD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 29.51%, EXOD belongs to the top of the industry, outperforming 97.15% of the companies in the same industry.
EXOD has a Return On Equity of 33.40%. This is amongst the best in the industry. EXOD outperforms 92.88% of its industry peers.
EXOD has a Return On Invested Capital of 4.85%. This is in the better half of the industry: EXOD outperforms 72.60% of its industry peers.
Industry RankSector Rank
ROA 29.51%
ROE 33.4%
ROIC 4.85%
ROA(3y)8.24%
ROA(5y)8.78%
ROE(3y)9.73%
ROE(5y)10.82%
ROIC(3y)N/A
ROIC(5y)N/A
EXOD Yearly ROA, ROE, ROICEXOD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

The Profit Margin of EXOD (73.05%) is better than 95.37% of its industry peers.
With a decent Operating Margin value of 13.42%, EXOD is doing good in the industry, outperforming 78.65% of the companies in the same industry.
EXOD's Operating Margin has declined in the last couple of years.
EXOD has a better Gross Margin (89.52%) than 96.09% of its industry peers.
EXOD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.42%
PM (TTM) 73.05%
GM 89.52%
OM growth 3Y-20.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.53%
GM growth 5Y42.83%
EXOD Yearly Profit, Operating, Gross MarginsEXOD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EXOD is destroying value.
The number of shares outstanding for EXOD has been increased compared to 1 year ago.
EXOD has more shares outstanding than it did 5 years ago.
There is no outstanding debt for EXOD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EXOD Yearly Shares OutstandingEXOD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
EXOD Yearly Total Debt VS Total AssetsEXOD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

EXOD has an Altman-Z score of 15.12. This indicates that EXOD is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 15.12, EXOD belongs to the top of the industry, outperforming 91.81% of the companies in the same industry.
There is no outstanding debt for EXOD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 15.12
ROIC/WACC0.43
WACC11.4%
EXOD Yearly LT Debt VS Equity VS FCFEXOD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 6.51 indicates that EXOD has no problem at all paying its short term obligations.
The Current ratio of EXOD (6.51) is better than 91.46% of its industry peers.
EXOD has a Quick Ratio of 6.51. This indicates that EXOD is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of EXOD (6.51) is better than 91.46% of its industry peers.
Industry RankSector Rank
Current Ratio 6.51
Quick Ratio 6.51
EXOD Yearly Current Assets VS Current LiabilitesEXOD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

7

3. Growth

3.1 Past

EXOD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 759.27%, which is quite impressive.
EXOD shows a strong growth in Revenue. In the last year, the Revenue has grown by 106.94%.
EXOD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 71.14% yearly.
EPS 1Y (TTM)759.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%404.2%
Revenue 1Y (TTM)106.94%
Revenue growth 3Y6.65%
Revenue growth 5Y71.14%
Sales Q2Q%15.77%

3.2 Future

The Earnings Per Share is expected to decrease by -10.34% on average over the next years. This is quite bad
Based on estimates for the next years, EXOD will show a very strong growth in Revenue. The Revenue will grow by 29.81% on average per year.
EPS Next Y-65.74%
EPS Next 2Y-30.17%
EPS Next 3Y-10.34%
EPS Next 5YN/A
Revenue Next Year23.72%
Revenue Next 2Y23.98%
Revenue Next 3Y29.81%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
EXOD Yearly Revenue VS EstimatesEXOD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
EXOD Yearly EPS VS EstimatesEXOD Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.55, EXOD is valued correctly.
Based on the Price/Earnings ratio, EXOD is valued cheaper than 85.77% of the companies in the same industry.
EXOD is valuated rather cheaply when we compare the Price/Earnings ratio to 27.32, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 24.45, which indicates a rather expensive current valuation of EXOD.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EXOD indicates a somewhat cheap valuation: EXOD is cheaper than 69.04% of the companies listed in the same industry.
EXOD is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.89, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.55
Fwd PE 24.45
EXOD Price Earnings VS Forward Price EarningsEXOD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EXOD is valued a bit cheaper than the industry average as 70.82% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 35.17
EXOD Per share dataEXOD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

EXOD has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as EXOD's earnings are expected to decrease with -10.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-30.17%
EPS Next 3Y-10.34%

0

5. Dividend

5.1 Amount

EXOD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EXODUS MOVEMENT INC - A

NYSEARCA:EXOD (9/26/2025, 8:04:02 PM)

After market: 28.317 -0.19 (-0.68%)

28.51

-0.39 (-1.35%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-10 2025-11-10
Inst Owners15.64%
Inst Owner Change79.18%
Ins Owners31.01%
Ins Owner Change2.67%
Market Cap828.79M
Analysts85.71
Price Target56.04 (96.56%)
Short Float %23.38%
Short Ratio3.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)202.96%
Min EPS beat(2)47.39%
Max EPS beat(2)358.52%
EPS beat(4)2
Avg EPS beat(4)62.74%
Min EPS beat(4)-89.5%
Max EPS beat(4)358.52%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.23%
Min Revenue beat(2)-10.79%
Max Revenue beat(2)-5.68%
Revenue beat(4)1
Avg Revenue beat(4)1.94%
Min Revenue beat(4)-18.8%
Max Revenue beat(4)43.03%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-9.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-64.29%
EPS NY rev (1m)26.84%
EPS NY rev (3m)-35.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.1%
Revenue NY rev (1m)0.69%
Revenue NY rev (3m)-16.33%
Valuation
Industry RankSector Rank
PE 14.55
Fwd PE 24.45
P/S 6.54
P/FCF N/A
P/OCF N/A
P/B 2.99
P/tB 22.57
EV/EBITDA 35.17
EPS(TTM)1.96
EY6.87%
EPS(NY)1.17
Fwd EY4.09%
FCF(TTM)-0.75
FCFYN/A
OCF(TTM)-0.74
OCFYN/A
SpS4.36
BVpS9.53
TBVpS1.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 29.51%
ROE 33.4%
ROCE 5.62%
ROIC 4.85%
ROICexc 6.01%
ROICexgc 357.43%
OM 13.42%
PM (TTM) 73.05%
GM 89.52%
FCFM N/A
ROA(3y)8.24%
ROA(5y)8.78%
ROE(3y)9.73%
ROE(5y)10.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-4.25%
ROICexcg growth 5YN/A
ROICexc growth 3Y-46.6%
ROICexc growth 5YN/A
OM growth 3Y-20.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.53%
GM growth 5Y42.83%
F-Score6
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 5.67%
Cap/Sales 0.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.51
Quick Ratio 6.51
Altman-Z 15.12
F-Score6
WACC11.4%
ROIC/WACC0.43
Cap/Depr(3y)6.53%
Cap/Depr(5y)64.28%
Cap/Sales(3y)0.39%
Cap/Sales(5y)2.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)759.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%404.2%
EPS Next Y-65.74%
EPS Next 2Y-30.17%
EPS Next 3Y-10.34%
EPS Next 5YN/A
Revenue 1Y (TTM)106.94%
Revenue growth 3Y6.65%
Revenue growth 5Y71.14%
Sales Q2Q%15.77%
Revenue Next Year23.72%
Revenue Next 2Y23.98%
Revenue Next 3Y29.81%
Revenue Next 5YN/A
EBIT growth 1Y329.05%
EBIT growth 3Y-15.6%
EBIT growth 5YN/A
EBIT Next Year-63.44%
EBIT Next 3Y8.31%
EBIT Next 5YN/A
FCF growth 1Y-2102.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1840.17%
OCF growth 3YN/A
OCF growth 5YN/A